跳至主要内容
临床试验/NCT07419074
NCT07419074已完成不适用

Hypoglycemic Potential of Garcinia Cambogia (Garcinia Gummi-gutta (L.) N.Robson) Rind Powder Among Pre-diebetic Obese Patients

University of Lahore1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年9月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Weight

研究概览

简要总结

Garcinia cambogia, rich in hydroxycitric acid (HCA), has been suggested to promote weight loss and improve metabolic parameters. Evidence regarding its efficacy in pre-diabetic obese adults remains limited.

Objective: To evaluate the effects of Garcinia cambogia rind powder supplementation on anthropometric, glycemic, lipid, hepatic, and renal parameters in pre-diabetic obese adults.

详细描述

The observed effects are likely mediated by HCA, which inhibits ATP-citrate lyase, reducing de novo lipogenesis, enhancing glucose utilization, and modulating adipokines and oxidative stress.

Conclusion: Garcinia cambogia rind powder supplementation exerts dose-dependent metabolic benefits in pre-diabetic obese adults, improving anthropometric, glycemic, lipid, hepatic, and renal parameters without adverse effects. It may serve as a complementary intervention alongside lifestyle modification for the management of obesity and pre-diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
30 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Participants of both genders were included if they were aged 30-60 years,
  • body mass index (BMI) ≥30 kg/m²,
  • Individuals with HbA1c levels ranging from 5.7% to 10% were selected, .indicating pre-diabetic to diabetic status. Participants were required to have a .body mass index (BMI) of 25 kg/m² or higher

排除标准

  • Participants who were diagnosed with type 1, pregnant or lactating,
  • chronic liver, kidney, or cardiovascular disease,
  • history of hepatotoxicity or gastrointestinal disorders,
  • using weight-loss supplements, steroids, or lipid-lowering drugs, or had a known allergy to Garcinia cambogia

研究组 & 干预措施

Placebo group

Placebo Comparator

Starch capsule once a day

干预措施: Garcinia cambogia rind powder (Dietary Supplement)

T1

Experimental

100mg/day of Garcinia cambogia rind powder

干预措施: Garcinia cambogia rind powder (Dietary Supplement)

T2

Experimental

200mg/day of Garcinia cambogia rind powder

干预措施: Garcinia cambogia rind powder (Dietary Supplement)

结局指标

主要结局

Weight

时间窗: 12 weeks

次要结局

  • Lipid profile(12 weeks)
  • fasting glucose(12 weeks)

研究者

发起方
University of Lahore
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验